Voraxaze glucarpidase regulatory update

FDA accepted and granted Priority Review to a BLA from BTG for Voraxaze glucarpidase to reduce methotrexate levels due to impaired renal function. The PDUFA date is Jan. 17, 2012. The product has Fas...